Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1200 participants.

Also called NCT04111419

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04111419
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04111419. Randomized; no masking; primary purpose treatment. Start 2020-07-01 (actual); primary completion 2026-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Condition
Hypertension
Intervention (Drug)
Amlodipine/Atorvastatin 5 Mg-20 Mg ORAL TABLET
Intervention (Drug)
Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET
Intervention (Drug)
Allisartan Isoproxil
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct04111419
Content hash
659eef0c17f39f6fdad1424efe925bdf8ebbec0f1033c79c0a5797f86e66c772